Kungsleden announces rights issue of approximately SEK

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Kungsleden announces rights issue of approximately SEK 1.5bn

Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, South Africa, the United States or any other jurisdiction where such distribution of this press release would be subject to legal restrictions. · Kungsleden’s Board of Directors has resolved to, subject to the approval by an Extraordinary General Meeting, launch a rights issue of approximately SEK 1.5bn with preferential rights for Kungsleden’s shareholders. The Extraordinary General Meeting will be held on 16 September 2014. · The reason for the rights issue is to enhance the financial flexibility and facilitate the company’s ability to realise its growth plans and thereby create additional shareholder value. · Complete terms and conditions of the rights issue, including subscription price, are expected to be announced no later than 12 September 2014. Subject to the approval of the rights issue by an Extraordinary General Meeting on 16 September 2014, the subscription period will run from 23 September up to and including 8 October 2014. “One and half years have now passed since we launched our new strategy and the implementation of it has so far exceeded expectations. We have refined and concentrated the property portfolio geographically and have significantly increased the share of properties in large city areas. We are now taking the next step and will become an active acquirer again. In order to facilitate for an acquisition pace according to our plan, we have decided to launch a rights issue of approximately SEK 1.5bn”, says Biljana Pehrsson, CEO of Kungsleden. Background and reasons In early 2013, Kungsleden launched a new strategy with a focus on active management, development and long term value creation of commercial properties. One part of the new strategy is to create a larger, geographically more concentrated, high quality property portfolio within selected property segments and geographical regions which are characterised by good economic growth and demand for premises. The goal is to generate an attractive total return and the ambition is to grow the property portfolio to a value of approximately SEK 30bn over time. Throughout 2013 and 2014 a number of large successful property acquisitions have been carried out in accordance with the new strategy, while properties deemed non-strategic have gradually been divested. Examples include the SEK 5.5bn property acquisition from GE Capital Real Estate in December 2013, the sale of Kungsleden’s 50 percent stake in Hemsö to the Third Swedish National Pension Fund for SEK 3.3bn with effect from February 2013, and, recently, the sale of 39 properties in northern Sweden to NP3 for SEK 760m with effect from September 2014. The transaction market has so far during 2014 generated high volumes and a number of large transactions. In an active transaction market environment, acquirers need good financial preparedness. In Kungsleden’s view, there are currently a number of potential transaction opportunities that would fit the company’s long term strategy. Consequently, the Board of Directors has resolved to, subject to the approval by an Extraordinary General Meeting, launch a rights issue of approximately SEK 1.5bn before issue costs with preferential rights for Kungsleden’s shareholders in order to increase Kungsleden’s financial flexibility and facilitate the company’s ability to realise its growth plans and thereby create additional shareholder value. The aim is to generate a profit before tax of SEK 1.0-1.2bn no later than 2017. Terms and conditions for the rights issue Shareholders in Kungsleden will have preferential rights to subscribe for new shares in proportion to their holdings. In the event that all shares are not subscribed for with subscription rights, the Board of Directors shall decide on allotment of shares subscribed for without the exercise of subscription rights up to the maximum amount of the rights issue, and such shares will be allocated to those who have also subscribed for shares by exercising subscription rights and applied for subscription of additional shares, irrespective of whether they were shareholders on the record date or not, pro rata to the number of subscription rights used for subscription of shares. To the extent allotment according to the above cannot be made pro rata, allotment shall be made by drawing of lots. The amount by which the share capital will be increased, the number of shares to be issued and the subscription price for the new shares are expected to be announced no later than 12 September 2014. The record date at Euroclear Sweden AB for participation in the rights issue with preferential rights is 19 September 2014. The subscription period (subscription through payment) will run from 23 September up to and including 8 October 2014, or such later date as decided by the Board of Directors. Trading in subscription rights is expected to take place from 23 September up to and including 3 October 2014. The decision to launch the rights issue is subject to approval by an Extraordinary General Meeting that will take place on Tuesday 16 September 2014 at 2:00 p.m. CET at Summit, Grev Turegatan 30, Stockholm. For more information, please see the notice for the Extraordinary General Meeting in a separate press release. Shareholder support Shareholders representing approximately 17 percent of the shares in Kungsleden, comprising Gösta Welandson (and related company) and Olle Florén (and related company), both represented on the Board of Directors, as well as the Second Swedish National Pension Fund have indicated that they are positive towards the rights issue and have expressed their intention to vote in favour of it at the Extraordinary General Meeting as well as subscribe for their pro rata shares of the issue. Indicative timetable for the rights issue 12 September 2014: Announcement of complete terms and conditions, including subscription price and subscription ratio 16 September 2014: Extraordinary General Meeting to decide on the rights issue resolved by the Board of Directors 16 September 2014: Last day of trading in the shares including right to participate in the rights issue 17 September 2014: First day of trading in the shares excluding right to participate in the rights issue 19 September 2014: Record date for participation in the rights issue, i.e. shareholders who are registered in the share register as of this day will receive subscription rights for participation in the rights issue 19 September 2014: Estimated date for the publication of the prospectus 23 September – 3 October 2014: Trading in subscription rights 23 September – 8 October 2014: Subscription period 13 October 2014: Announcement of preliminary results of the rights issue For more information, please contact: Biljana Pehrsson, Chief Executive of Kungsleden | +46 (0)8 503 052 04 | biljana.pehrsson@kungsleden.se Anders Kvist, Deputy CEO and CFO of Kungsleden | +46 (0)8 503 052 11 | anders.kvist@kungsleden.se www.kungsleden.se Detta pressmeddelande finns tillgängligt på svenska på www.kungsleden.se/pressmeddelanden Kungsleden AB (publ) discloses the information in this press release according to the Swedish Securities Markets Act and/or the Swedish Financial Trading Act. The information was provided for public release on 15 August 2014 at 7:30 a.m. Kungsleden’s business concept is to own, manage and improve commercial properties in growth regions in Sweden and to deliver attractive total returns. Kungsleden’s strategies to create value are based on meeting the premises requirements of customers by managing, improving and developing properties and planning consents and by optimising the company’s property portfolio. Kungsleden has been quoted on NASDAQ OMX Stockholm since 1999. Important information The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Kungsleden. Any invitation to the persons concerned to subscribe for shares in Kungsleden will only be made through the prospectus that Kungsleden estimates to publish on or around 19 September 2014. This press release may not be released, published or distributed, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, South Africa, the United States or any other jurisdiction where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this press release be forwarded, reproduced or disclosed in a manner that contravenes such restrictions or would entail such requirements. Failure to comply with this instruction may result in a violation of applicable securities laws. No subscription rights, BTAs (interim shares) or new shares have or will be registered under the United States Securities Act of 1933 (“Securities Act”) or securities legislation in any state or other jurisdiction in the United States and may not be offered, subscribed, sold or transferred, directly or indirectly, within the United States, other than pursuant to an exemption from the registration requirements of the Securities Act and in accordance with securities laws in relevant state or other jurisdiction in the United States. This press release may contain forward-looking statements which reflect Kungsleden’s current view on future events and financial and operational development. Words such as “intend”, “expect”, “anticipate”, “may”, “believe”, “plan”, “estimate” and other expressions which imply indications or predictions of future development or trends, and which are not based on historical facts, are intended to identify forward-looking statements. Forward-looking statements inherently involve both known and unknown risks and uncertainties as they depend on future events and circumstances. Forward-looking statements do not guarantee future results or development and the actual outcome could differ materially from the forward-looking statements.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 133

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 404

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 207

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 164

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 315

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Standex International Corporation Delivers Strong Q1 Results

Updated Category News Views 140

Standex Reports Fiscal First Quarter Results Standex International Corporation (NYSE: SXI) has recently released its financial results for the first quarter of fiscal year 2026, marking a substantial increase in performance compared to the previous year. With sales soaring by 27.6% year-over-year to reach $217.4 million, the company has shown incredible resilience and...

Continue Reading
Nasdaq 100 Surges Towards Record Highs Driven by Tech Giants

Updated Category News Views 241

Nasdaq 100 Approaching Historic Peaks Recently, the Nasdaq 100 futures have shown notable resilience, climbing more than 3% as they responded positively to key support levels established the prior week. Currently, the index is flirting with new all-time highs, merely 300 points away from breaking past significant barriers that could reshape market expectations. Key...

Continue Reading
Investigation Announced for Jayud Global Logistics Investors

Updated Category News Views 190

Investigation Announced for Jayud Global Logistics Investors Attention shareholders of Jayud Global Logistics Limited (NASDAQ: JYD). Recent developments surrounding this company have led to significant concerns about the accuracy of their public statements. An investigation is currently being initiated for investors who may have incurred losses. The Nature of the...

Continue Reading
Adona Medical Advances Heart Failure Management with Shunt

Updated Category News Views 324

Adona Medical's First-in-Human Study on Innovative Shunt Adona Medical, a company well-known for its cutting-edge solutions for heart failure management, recently made significant strides with its new interatrial shunt technology. The company is spearheading its first-in-human study to assess the capabilities of this innovative device, which aims to enhance the...

Continue Reading
Hyundai Motor Reports Decline in Q3 Profit Amid Demand Drop

Updated Category News Views 174

Hyundai Motor's Q3 Profit Decline: Key Insights Hyundai Motor Co, a leading name in the automotive sector, has announced a noteworthy decline in its third-quarter operating profit. This shift marks a 7% decrease compared to the previous year's performance, signaling the impact of a global slowdown in car demand on the company. Understanding the Financial Figures For the...

Continue Reading